104 related articles for article (PubMed ID: 33977235)
1. Antiviral mechanism of preclinical antimalarial compounds possessing multiple antiviral activities.
Gu W; Ueda Y; Dansako H; Satoh S; Kato N
FASEB Bioadv; 2021 May; 3(5):356-373. PubMed ID: 33977235
[TBL] [Abstract][Full Text] [Related]
2. Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251.
Ueda Y; Gu W; Dansako H; Kim HS; Yoshizaki S; Okumura N; Ishikawa T; Nishitsuji H; Kato F; Hishiki T; Satoh S; Ishii K; Masuda M; Shimotohno K; Ikeda M; Kato N
Biochem Biophys Rep; 2018 Sep; 15():1-6. PubMed ID: 30023438
[TBL] [Abstract][Full Text] [Related]
3. Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
Murayama A; Sugiyama N; Suzuki R; Moriyama M; Nakamura N; Mochizuki H; Wakita T; Kato T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928005
[TBL] [Abstract][Full Text] [Related]
4. Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system.
Contreras AM; Hiasa Y; He W; Terella A; Schmidt EV; Chung RT
J Virol; 2002 Sep; 76(17):8505-17. PubMed ID: 12163570
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the roles of the 5' exoribonucleases Xrn1 and Xrn2 in restricting hepatitis C virus replication.
Li Y; Yamane D; Lemon SM
J Virol; 2015 May; 89(9):4857-65. PubMed ID: 25673723
[TBL] [Abstract][Full Text] [Related]
6. Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype.
Namba K; Naka K; Dansako H; Nozaki A; Ikeda M; Shiratori Y; Shimotohno K; Kato N
Biochem Biophys Res Commun; 2004 Oct; 323(1):299-309. PubMed ID: 15351737
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system.
Chung RT; He W; Saquib A; Contreras AM; Xavier RJ; Chawla A; Wang TC; Schmidt EV
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9847-52. PubMed ID: 11493707
[TBL] [Abstract][Full Text] [Related]
8. Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.
Wolfisberg R; Holmbeck K; Nielsen L; Kapoor A; Rice CM; Bukh J; Scheel TKH
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292246
[TBL] [Abstract][Full Text] [Related]
9. In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122.
Ottosen S; Parsley TB; Yang L; Zeh K; van Doorn LJ; van der Veer E; Raney AK; Hodges MR; Patick AK
Antimicrob Agents Chemother; 2015 Jan; 59(1):599-608. PubMed ID: 25385103
[TBL] [Abstract][Full Text] [Related]
10. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells.
Ikeda M; Yi M; Li K; Lemon SM
J Virol; 2002 Mar; 76(6):2997-3006. PubMed ID: 11861865
[TBL] [Abstract][Full Text] [Related]
11. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs.
Krönke J; Kittler R; Buchholz F; Windisch MP; Pietschmann T; Bartenschlager R; Frese M
J Virol; 2004 Apr; 78(7):3436-46. PubMed ID: 15016866
[TBL] [Abstract][Full Text] [Related]
12. Identification of host genes showing differential expression profiles with cell-based long-term replication of hepatitis C virus RNA.
Sejima H; Mori K; Ariumi Y; Ikeda M; Kato N
Virus Res; 2012 Jul; 167(1):74-85. PubMed ID: 22579597
[TBL] [Abstract][Full Text] [Related]
13. Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology.
Ng TI; Mo H; Pilot-Matias T; He Y; Koev G; Krishnan P; Mondal R; Pithawalla R; He W; Dekhtyar T; Packer J; Schurdak M; Molla A
Hepatology; 2007 Jun; 45(6):1413-21. PubMed ID: 17518369
[TBL] [Abstract][Full Text] [Related]
14. Anti-ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis C.
Ikeda M; Kawai Y; Mori K; Yano M; Abe K; Nishimura G; Dansako H; Ariumi Y; Wakita T; Yamamoto K; Kato N
Liver Int; 2011 Jul; 31(6):871-80. PubMed ID: 21645219
[TBL] [Abstract][Full Text] [Related]
15. Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets.
Blight KJ; Kolykhalov AA; Reed KE; Agapov EV; Rice CM
Antivir Ther; 1998; 3(Suppl 3):71-81. PubMed ID: 10726057
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z
J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997
[TBL] [Abstract][Full Text] [Related]
17. Natural prevalence of hepatitis C virus (HCV) variants resistant to protease and polymerase inhibitors in patients infected with HCV genotype 1 in Tunisia.
Aissa Larousse J; Trimoulet P; Recordon-Pinson P; Papuchon J; Azzouz MM; Ben Mami N; Cheikh I; Triki H; Fleury H
J Med Virol; 2014 Aug; 86(8):1350-9. PubMed ID: 24760718
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of intracellular inhibition of hepatitis C virus replication by small interfering RNAs.
Chang B; Lee CH; Lee JH; Lee SW
Biotechnol Lett; 2010 Sep; 32(9):1231-7. PubMed ID: 20464448
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-135a Modulates Hepatitis C Virus Genome Replication through Downregulation of Host Antiviral Factors.
Sodroski C; Lowey B; Hertz L; Jake Liang T; Li Q
Virol Sin; 2019 Apr; 34(2):197-210. PubMed ID: 30456659
[TBL] [Abstract][Full Text] [Related]
20. Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cells.
Rehman S; Ashfaq UA; Ijaz B; Riazuddin S
Microb Pathog; 2018 Aug; 121():198-209. PubMed ID: 29775725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
